As of 2025-07-04, the Intrinsic Value of VG Life Sciences Inc (VGLS) is -0.10 USD. This VGLS valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.00 USD, the upside of VG Life Sciences Inc is -101,990.00%.
Based on its market price of 0.00 USD and our intrinsic valuation, VG Life Sciences Inc (VGLS) is overvalued by 101,990.00%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -0.10 - -0.10 | -0.10 | -101,990.00% |
| DDM - Stable | (0.00) - (0.01) | (0.01) | -6036.9% |
| DDM - Multi | (0.00) - (0.00) | (0.00) | -2772.7% |
| Market Cap (mil) | 0.02 |
| Beta | 87.78 |
| Outstanding shares (mil) | 210.95 |
| Enterprise Value (mil) | 3.38 |
| Market risk premium | 4.60% |
| Cost of Equity | 358.68% |
| Cost of Debt | 5.00% |
| WACC | 5.60% |